Oxypurinol alkali and alkaline earth salts in amorphorous or cry

Details Oxypurinol alkali and alkaline earth salts in amorphorous or cry Oxypurinol alkali and alkaline earth salts in amorphorous or cry

1995-02-06

1997-08-26

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 3152

Patent

active

056611544

ABSTRACT:
Treatment of hyperuricaemia and gout is possible by agents, among usual carriers and adjuvants containing pharmakologically active doses of oxypurinol alkali and/or alkaline earth salts in amorphous or crystalline form.

REFERENCES:
patent: 3624205 (1971-11-01), Hitchings et al.
patent: 5368864 (1994-11-01), Lahr et al.
patent: 5430037 (1995-07-01), Scheiffele
Handbook of Pharmaceutical Excipients (1986), pp. 138-140.
Martindale, The Extra Pharmacopoeia, 28th Ed. (1982), pp. 417-419.
Lachman et al. "The Theory and Practice of Industrial Pharmacy", 2nd edition, pp. 99-104 1976.

Affiliated with

Also associated with

Rating

Oxypurinol alkali and alkaline earth salts in amorphorous or cry does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxypurinol alkali and alkaline earth salts in amorphorous or cry, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxypurinol alkali and alkaline earth salts in amorphorous or cry will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1988706